Royal Bank of Canada’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.13M Buy
74,734
+64,770
+650% +$3.58M ﹤0.01% 2482
2025
Q1
$482K Buy
9,964
+2,334
+31% +$113K ﹤0.01% 3703
2024
Q4
$295K Sell
7,630
-5,933
-44% -$229K ﹤0.01% 4046
2024
Q3
$610K Buy
13,563
+3,341
+33% +$150K ﹤0.01% 3535
2024
Q2
$354K Buy
10,222
+4,543
+80% +$157K ﹤0.01% 3923
2024
Q1
$165K Sell
5,679
-11,776
-67% -$342K ﹤0.01% 4417
2023
Q4
$400K Buy
17,455
+9,396
+117% +$215K ﹤0.01% 3955
2023
Q3
$134K Buy
8,059
+3,842
+91% +$63.9K ﹤0.01% 4675
2023
Q2
$116K Buy
4,217
+1,583
+60% +$43.5K ﹤0.01% 4778
2023
Q1
$61K Sell
2,634
-2,909
-52% -$67.4K ﹤0.01% 5137
2022
Q4
$60K Buy
5,543
+4,732
+583% +$51.2K ﹤0.01% 5306
2022
Q3
$7K Buy
811
+301
+59% +$2.6K ﹤0.01% 6115
2022
Q2
$4K Sell
510
-2,490
-83% -$19.5K ﹤0.01% 6283
2022
Q1
$71K Sell
3,000
-7,067
-70% -$167K ﹤0.01% 5384
2021
Q4
$345K Buy
10,067
+5,282
+110% +$181K ﹤0.01% 4301
2021
Q3
$85K Buy
4,785
+1,455
+44% +$25.8K ﹤0.01% 5313
2021
Q2
$149K Buy
3,330
+6
+0.2% +$268 ﹤0.01% 4844
2021
Q1
$86K Buy
3,324
+2,134
+179% +$55.2K ﹤0.01% 5072
2020
Q4
$24K Buy
1,190
+690
+138% +$13.9K ﹤0.01% 5431
2020
Q3
$10K Hold
500
﹤0.01% 5435
2020
Q2
$9K Buy
500
+448
+862% +$8.06K ﹤0.01% 5394
2020
Q1
$0 Sell
52
-1,050
-95% ﹤0.01% 6287
2019
Q4
$8K Buy
+1,102
New +$8K ﹤0.01% 5622
2019
Q1
Sell
-500
Closed -$3K 5879
2018
Q4
$3K Sell
500
-7
-1% -$42 ﹤0.01% 5465
2018
Q3
$5K Buy
507
+107
+27% +$1.06K ﹤0.01% 5661
2018
Q2
$3K Buy
400
+220
+122% +$1.65K ﹤0.01% 5592
2018
Q1
$2K Buy
180
+109
+154% +$1.21K ﹤0.01% 5505
2017
Q4
$1K Sell
71
-687
-91% -$9.68K ﹤0.01% 5650
2017
Q3
$13K Buy
758
+706
+1,358% +$12.1K ﹤0.01% 5420
2017
Q2
$1K Sell
52
-191
-79% -$3.67K ﹤0.01% 5667
2017
Q1
$3K Sell
243
-114
-32% -$1.41K ﹤0.01% 5672
2016
Q4
$8K Buy
357
+157
+79% +$3.52K ﹤0.01% 5397
2016
Q3
$4K Buy
+200
New +$4K ﹤0.01% 5268